Clarity Medical Group Holding Limited (HKG:1406)
Hong Kong · Delayed Price · Currency is HKD 0.3550
+0.0200 (5.97%)
Apr 14, 2025, 9:50 AM HKT
HKG:1406 Balance Sheet
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 92.02 | 132.57 | 141.43 | 207.5 | 241.27 |
Short-Term Investments | 1.15 | - | - | - | - |
Cash & Short-Term Investments | 93.17 | 132.57 | 141.43 | 207.5 | 241.27 |
Cash Growth | -29.72% | -6.26% | -31.84% | -14.00% | 271.97% |
Accounts Receivable | 5.33 | 4.79 | 2.65 | 1.96 | 1.11 |
Other Receivables | 0.26 | - | 1.41 | 1.05 | 0.91 |
Receivables | 5.59 | 4.79 | 18.5 | 17.43 | 2.01 |
Inventory | 2.19 | 2.52 | 3.58 | 3.68 | 3.75 |
Prepaid Expenses | 0.98 | - | - | - | 0.6 |
Other Current Assets | - | 3.71 | 5.7 | 5.06 | 1.97 |
Total Current Assets | 101.92 | 143.58 | 169.21 | 233.66 | 249.59 |
Property, Plant & Equipment | 49.64 | 39.39 | 52.63 | 78.25 | 37.81 |
Long-Term Investments | 4.63 | 4.38 | - | - | - |
Long-Term Deferred Tax Assets | 10.72 | 9.06 | 6.43 | 0.33 | 0.59 |
Other Long-Term Assets | 3.1 | 3.3 | 7.89 | 15.02 | 2.14 |
Total Assets | 170.01 | 199.7 | 236.16 | 327.26 | 290.14 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 6.61 | 5.63 | 4.77 | 7.17 | 5.88 |
Accrued Expenses | 11.3 | 14.69 | 12 | 3.25 | 7.39 |
Current Portion of Leases | 11.86 | 7.69 | 19.18 | 21.96 | 10.93 |
Current Unearned Revenue | 1.48 | 1.26 | 0.09 | - | - |
Other Current Liabilities | - | 5.73 | 2.3 | 7.83 | - |
Total Current Liabilities | 31.25 | 35 | 38.33 | 40.2 | 24.2 |
Long-Term Leases | 16.64 | 2.22 | 6.23 | 25.3 | 9.25 |
Other Long-Term Liabilities | 4.69 | 1.19 | 2.08 | 2.48 | 1.25 |
Total Liabilities | 52.57 | 38.41 | 46.64 | 67.98 | 34.69 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 5.36 | 5.29 | 5.28 | 5.28 | 5.1 |
Additional Paid-In Capital | 312.75 | 306.42 | 306.39 | 306.39 | 292.9 |
Retained Earnings | -193.92 | -147.51 | -113.22 | -37.43 | -34.24 |
Comprehensive Income & Other | -6.75 | -2.9 | -8.93 | -14.96 | -8.31 |
Shareholders' Equity | 117.44 | 161.29 | 189.52 | 259.28 | 255.45 |
Total Liabilities & Equity | 170.01 | 199.7 | 236.16 | 327.26 | 290.14 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 28.49 | 9.91 | 25.41 | 47.26 | 20.18 |
Net Cash (Debt) | 64.68 | 122.67 | 116.02 | 160.24 | 221.1 |
Net Cash Growth | -47.27% | 5.73% | -27.59% | -27.53% | 317.92% |
Net Cash Per Share | 0.12 | 0.23 | 0.22 | 0.31 | 0.57 |
Filing Date Shares Outstanding | 536.33 | 528.92 | 528.13 | 528.13 | 509.72 |
Total Common Shares Outstanding | 536.33 | 528.92 | 528.13 | 528.13 | 509.72 |
Working Capital | 70.68 | 108.59 | 130.88 | 193.46 | 225.4 |
Book Value Per Share | 0.22 | 0.30 | 0.36 | 0.49 | 0.50 |
Tangible Book Value | 117.44 | 161.29 | 189.52 | 259.28 | 255.45 |
Tangible Book Value Per Share | 0.22 | 0.30 | 0.36 | 0.49 | 0.50 |
Machinery | 74.35 | 73.68 | 73.3 | 55.84 | 42.21 |
Leasehold Improvements | 63.68 | 63.68 | 55.65 | 33.41 | 21.59 |